Form 8-K - Current report:
SEC Accession No. 0001472375-25-000037
Filing Date
2025-04-02
Accepted
2025-04-02 15:16:28
Documents
13
Period of Report
2025-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ixform8k.htm   iXBRL 8-K 18760
  Complete submission text file 0001472375-25-000037.txt   185352

Data Files

Seq Description Document Type Size
2 SCHEMA DOCUMENT reg1357878-20250331.xsd EX-101.SCH 2720
3 LABELS LINKBASE DOCUMENT reg1357878-20250331_lab.xml EX-101.LAB 34011
4 PRESENTATION LINKBASE DOCUMENT reg1357878-20250331_pre.xml EX-101.PRE 22156
15 EXTRACTED XBRL INSTANCE DOCUMENT ixform8k_htm.xml XML 3353
Mailing Address 5348 VEGAS DRIVE, SUITE 177 LAS VEGAS NV 89108
Business Address 5348 VEGAS DRIVE, SUITE 177 LAS VEGAS NV 89108 305-927-5191
REGENEREX PHARMA, INC. (Filer) CIK: 0001357878 (see all company filings)

EIN.: 980479983 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53230 | Film No.: 25803858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)